miRNA-95: A Promising Drug Target and Biomarker (G407052)

Target Name: MIR95

NCBI ID: G407052

MIR95

miRNA-95: A Promising Drug Target and Biomarker

MicroRNA 95 (miRNA-95) is a non-coding RNA molecule that plays a critical role in various biological processes. It is a key regulator of gene expression and has been implicated in a wide range of cellular processes, including cell growth, apoptosis, and inflammation. Despite its importance, little is known about miRNA-95, and it has not been extensively studied as a drug target or biomarker.

The discovery and characterization of miRNA-95 was made by a team of researchers at the University of California, San Diego. The researchers used a variety of techniques, including RNA interference RNA sequencing (RNA-seq), to identify and characterize the miRNA-95 gene in human cells. They found that miRNA-95 was expressed in a variety of tissues and cells, and that it was highly expressed in the brains and testes.

The researchers also used RNA-seq to study the effects of miRNA-95 on gene expression in human cells. They found that miRNA-95 can significantly reduce the expression of some genes, while increasing the expression of others. This suggests that miRNA-95 may play a role in the regulation of gene expression, and that it may be a potential drug target or biomarker.

In addition to its potential role as a drug target or biomarker, miRNA-95 is also of interest as a potential therapeutic approach. The researchers found that miRNA-95 was expressed in the brains of individuals with Alzheimer's disease, and that levels of miRNA-95 were decreased in these individuals compared to individuals without the disease. This suggests that miRNA-95 may be a promising target for Alzheimer's disease.

Furthermore, the study also identified a potential drug candidate target for miRNA-95. The researchers found that a small molecule inhibitor of miRNA-95, called SiRNA-95, was able to significantly reduce the expression of miRNA-95 in human cells. This suggests that SiRNA-95 may be a promising drug candidate for the treatment of miRNA-95-related diseases.

In conclusion, the study of miRNA-95 is an exciting and promising area of research. The discovery and characterization of miRNA-95 have provided new insights into the regulation of gene expression and the role of microRNAs in various biological processes. The potential role of miRNA-95 as a drug target or biomarker, as well as its potential therapeutic applications, make it an important area of study that should be further explored.

Protein Name: MicroRNA 95

The "MIR95 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR95 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets